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Abstract IgG can be denatured in vitro by reactive oxygen 
species (ROS). Native IgG activates the complement cascade 
through Clq. Using a modified ELISA, Clq binding activity of 
rheumatoid IgG has been compared to lgG denatured by 
neutrophil-derived ROS. The Clq binding activity of rheumatoid 
synovial fluid IgG is greater than the corresponding serum IgG 
(P < 0.01). Denaturation of IgG by activated polymorphs or the 
Fenton reaction decreased its Clq binding activity (P < 0.01). In 
vitro exposure of lgG to OH" and ROO" increased its interaction 
with Clq (P< 0.01). Hypochlorous acid had no effect. ROS- 
induced alteration to IgG-Clq binding activity may promote the 
inflammatory response in rheumatoid arthritis. 
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1. Introduction 
During the initial acute phase inflammatory esponse, neu- 
trophils are recruited to the site of injury and activated to 
release proteolytic omponents and generate reactive oxygen 
species (ROS) [1,2]. These include hydrogen peroxide (H202), 
hypochlorous acid (HOC1), the hydroxyl radical (OH'), the 
superoxide anion radical (02"-) and peroxy radicals derived 
from ROS-induced lipid peroxidation (LOO'). ROS are highly 
reactive with biomolecules and can induce autoaggregation 
and molecular changes within proteins, where the target pro- 
tein is defined by its size, concentration a d constituent amino 
acids [3,4]. Within the rheumatoid joint, IgG levels are raised 
as a result of de novo synthesis in situ [5]. It has previously 
been shown that IgG from rheumatoid synovial fluids exhibits 
macromolecular nd molecular changes typical to those seen 
following ROS-induced enaturation i  vitro [6]. 
The activation of complement is also an important feature 
of the acute inflammatory esponse against bacteria. The trig- 
gering event in the activation of complement via the classical 
pathway involves the binding of the Fc region of aggregated 
IgG1, 2, 3 or IgM to the Clq component of C1, and culmi- 
nates in the formation of a membrane attack complex that 
mediates target cell lysis. The multivalency of Clq, each of six 
subunits possessing its own Fc binding site, has been proposed 
to explain the strong enhancement of binding to complexed 
IgG [7].The motif on IgG that binds Clq involves a number 
of charged residues: Glu 318, Lys 320 and Lys 322 [8]. In 
close proximity to this binding motif lies a fold at proline 
332 which also contributes to the IgG-Clq binding site [9]. 
Furthermore, studies on the role of the glycoform using a 
mouse/human chimeric antibody have demonstrated that the 
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absence of the carbohydrate moiety leads to deficiencies in 
Clq binding and activation [10]. 
Physicochemical bnormalities have been reported in IgG 
isolated from rheumatoid patients, and we have previously 
shown that ROS can induce such modifications [I 1]. Herein 
we have studied IgG isolated from rheumatoid biofluids for 
differences in Clq binding capacity compared to IgG isolated 
from non-inflammatory control sera. In addition, we have 
investigated the effects of neutrophil-derived oxidants on the 
capacity of IgG to bind Clq in order (a) to examine the effects 
of different ROS and (b) to investigate he possibility of ROS- 
induced functional modifications during inflammation. Such a 
denatured IgG molecule may act in a proinflammatory man- 
ner in rheumatoid arthritis through increased activation of 
complement. 
2. Materials and methods 
2.1. Materials 
All biochemical nd immunochemical reagents were of the highest 
grades available from Sigma (Poole, UK) unless otherwise stated. 
Polyclonal IgG, and Clq were from CalBiochem (Nottingham, 
UK). Phosphate-buffered saline pH 7.2 (PBS) containing 0.05% 
Tween 20 (PBST) was used as a washing buffer between all ELISA 
steps. Concentrated sulphuric acid and buffer salts were of Analar 
grade from BDH (Poole, UK). Nunc-Immuno plates were supplied 
by Gibco-BRL. 
2.2. Patients 
Specimens used in this study were obtained from patients with 
classical rheumatoid arthritis (as defined by the American Rheuma- 
tism Association) attending rheumatology clinics at Selly Oak Hospi- 
tal, Birmingham (mean age = 58, range 37-81). Patients receiving ster- 
oids were excluded from the study. Elderly control sera were obtained 
from informed volunteers (mean age 67 years) from orthopaedic pa- 
tients within the South Birmingham Health Authority. 
2.3. Isolation of lgGfrom biological fluids 
For the isolation of IgG from rheumatoid synovial fluids, the vis- 
cosity of the fluid was initially reduced by incubation overnight with 
hyaluronidase. (This procedure had no effect on the Clq binding 
activity of hyaluronidase-treated serum samples when compared to 
untreated control sera.) The resultant samples were then extracted 
as for serum samples. The isolation method has been described by 
Perosa et al. [12], and briefly involves the capryllic acid-induced pre- 
cipitation of IgG from serum. The purity of the IgG preparation was 
confirmed by immunoelectrophoresis. 
2.4. Denaturation of IgG & vitro 
In order to generate defined radical species in solution, IgG (1 rag/ 
ml in 40 mM phosphate buffer, pH 7.2) was exposed to steady-state "/ 
radiolysis as previously described [13], for doses of 0, 250, 500 and 
1000 Gy at a rate of 11 Gy/min. In aerated solution, a mixture of 
hydroxyl radical (OH') and superoxide anion radical (02-') are pro- 
duced in a 2:1 ratio. The incorporation of I00 mM formate into the 
irradiation buffer esults in the generation of the 02-" alone. The 
presence of 10 mM phenylalanine l ads to the scavenging of all 
OH" and 02-" to generate the peroxy radical (ROO') according to 
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the equations below [14]: 
Phe+H20& Phe(OH') +H + +e2q 
Phe(OH') ~Phe(OH)OO" 
To mimic the site-specific generation of OH" at metal ion binding 
sites on a protein backbone, 20 gM copper sulphate was incorporated 
into 0.01 M PBS containing IgG (1 mg/ml) followed by the addition 
of increasing doses of H202 (Cu/H202). 
To simulate the primary source of radicals at the inflammatory site, 
polymorphonuclear leukocytes (PMNs) were isolated from the periph- 
eral venous blood of normal healthy volunteers, and activated in vitro 
using phorbol myristate acetate (PMA). Briefly, PMNs were isolated 
by differential centrifugation using mono-poly resolving medium and 
contaminating erythrocytes were lysed using Tris-ammonium chloride 
buffer pH 7.2. Leishman's stained smears howed greater than 90%) of 
cells to be PMNs. Following three washes in RPMI 1640, PMNs were 
resuspended to a final concentration of 2× 106 viable cells per ml in 
the presence of 20 gg/ml cytochalasin B. The cell suspensions were 
preincubated at 37°C for 15 min prior to activation with 10 ng/ml 
PMA. To denature IgG, PMNs were activated as described in the 
presence of 1 mg/ml IgG, whilst control experiments were carried 
out with IgG and PMNs in the absence of a stimulus. The amount 
of 02-" generated (in nmol/106 cells) was calculated as the superoxide 
dismutase inhibitable reduction of 160 gM cytochrome c from PMA- 
activated cells in the absence of IgG, given that the latter has an 
extinction coefficient of 21×10 a mo1-1 cm -1 at 550 nm. IgG was 
also denatured using hypochlorous acid (HOCI) freshly prepared 
from sodium hypochlorite in water. HOC1 concentration was deter- 
mined spectrophotometrically using the molar extinction coefficient of 
350 M -1 at 290 nm, and IgG was treated with 0-200 taM HOC1 for 1 h 
at 37°C. 
2.5. Clq binding assay 
Using a modified ELISA procedure, 50 gl human Clq (10 lag/ml) 
was coated onto Nunc microtitre plates at pH 9.6 in carbonate/bicar- 
bonate buffer for 1 h at 37°C. After 3 washes in PBST, unoccupied 
sites on the plates were blocked for 1 h at 37°C using 1% bovine 
serum albumin. IgG (1 mg/ml in PBS) was allowed to interact with 
the immobilised Clq ligand, and the degree of binding was assessed 
using a peroxidase-labelled anti-human IgG diluted 1 : 1000 in PBST. 
No reaction was observed between the peroxidase-labelled anti-human 
IgG and the immobilised Clq. After washing, the reaction of perox- 
idase with 50 gM H202 and 20 mg ortho-phenylene diamine was 
allowed to proceed at room temperature for 30 min, and was stopped 
by the addition of 2 M H2SO4. The plate was then read at 492 nm in 
a Titertek multiscan. 
2.6. Statistical analysis 
Statistical analysis was carried out using Student's t-test for in vitro 
studies, and a parametric distribution of results was assumed. A non- 
parametric paired comparison test, Wilcoxon matched pairs, was used 
for assessing the differences between synovial fluid IgG and paired 
serum IgG. 
3. Results 
3.1. Clq binding activity of lgG isolated from biofluids 
The interaction of isolates of IgG from rheumatoid serum 
and synovial fluid (SF) with C lq  is shown in Fig. 1. Rheu- 
matoid SF IgG was found to bind more effectively to C lq  
than its paired serum IgG, but no significant difference was 
observed between rheumatoid serum IgG and normal serum 
IgG. 
3.2. The effects of steady-state ~ radiolysis on IgG-Clq 
interaction 
The effects of different radiolytically generated ROS on the 
ability of IgG to interact with C lq  are shown in Fig. 2. Super- 
oxide radical treatment had no significant effect on the C lq  
binding capacity of IgG. However, in the presence of OH', 
there was a significant increase in the ability of IgG to bind to 
C lq  up to a dose of 500 Gy. After a dose of 1000 Gy, this 
effect was less marked and binding was only increased by 20% 
above control levels. In contrast, ROO" induced a dose- 
dependent linear increase in the C lq  binding capacity of 
IgG at all doses studied, giving a 30% increase after exposure 
to 1000 Gy. 02-" had no effect on IgG binding to C lq  at any 
of the doses studied. 
3.3. The effects of site-specific generation of ROS by Cu/H2 02 
on IgG-Cl q interaction 
Following the addition of H202 to IgG in the presence of 
Cu, a significant loss in reactivity with C lq  was observed (see 
Table 1). The loss of 50% of C lq  binding activity occurred 
after exposure to 200 gM H202, and further increasing the 
H202 concentration had no effect (data not shown). 
3.4. The effects of HOCl on IgG-Clq binding 
The treatment of IgG with HOC1 had no effect on its sub- 
sequent interaction with C lq  (see Table 1). 
3.5. The effects of activated PMNs on IgG-Clq interaction 
The binding of PMN-denatured IgG to C lq  was found to 
be significantly lowered by 26% compared to that of the na- 
tive molecule (P< 0.01, n =4) using paired comparison ana- 
lysis (see Table 2). 
4. Discussion 
one of the consistently observed features of rheumatoid 
arthritis is the local consumption of complement by joint 
fluids, with the corresponding appearance of C3 activation 
products [15,16]. Indeed, complement fixation by immune 
complexes has been considered to play a central role in the 
pathogenesis of rheumatoid inflammation. The presence of 
high concentrations of aggregates could partially explain this 
observation. Another possibility is the occurrence of a dena- 
tured form of IgG with a higher affinity for C lq ,  and we have 
Table 1 
Effects of denaturation of IgG by ROS on the subsequent interaction of IgG with Clq: the effects of hypochlorous acid and hydrogen peroxide 
on IgG interaction with Clq 
ROS IgG bound to Clq--absorbance at492 nm+ SEM × 103 
Concentration 0 20 50 200 
(gM) 
Hydrogen peroxide with copper (20 gM) 115 + 8 94 + 14" 65 + 6** 56 + 11"* 
Hypochlorous acid 99 + 10 101 +_ 15 95 + 2 96 + 2 
The results show the amount of IgG bound to immobilised Clq determined spectrophotometrically t 492 nm following treatment of IgG with 
HOC1 and H202. 
*P < 0.05, **P < 0.01 compared with untreated controls (n = 3). 
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Fig. 1. The ability of IgG isolated from elderly and rheumatoid 
sera, and rheumatoid synovial fluid to bind Clq in the modified 
ELISA. Results are the means of triplicate determinations for each 
isolate, and the mean for each group is indicated by a horizontal 
bar. Paired comparison analysis was used to statistically analyse the 
paired sera and SFs, where 80% of SF IgGs gave higher values 
than serum; **P< 0.01. 
investigated whether ROS-induced amage to IgG can med- 
iate such changes. 
When a comparison is made between isolated IgG from 
rheumatoid serum and paired synovial fluids, an increase in 
binding capacity is seen in the latter. This may be due to the 
presence of IgG rheumatoid factors in the isolated samples, 
which lead to autoaggregation [17] and thus an increase in the 
valency of the IgG molecules involved in Clq binding. Con- 
versely, the higher binding activity of SF IgG compared to 
serum may reflect isotypic variation between the samples; 
IgG3 is secreted at higher levels in the SF [18] and this isotype 
has a much higher affinity constant for Clq than the major 
paraprotein IgG1 [19]. However, increases in autofluorescence 
in synovial fluid IgG are observed characteristic of ROS-in- 
duced damage, supporting the hypothesis that ROS may be 
important in modifying the physicochemical properties and 
the binding activities of IgG [6]. 
The results have shown that OH" exposure, which we have 
previously reported as inducing autofluorescence and aggrega- 
tion of IgG [191, increases the avidity of IgG for Clq up to a 
dose of 500 Gy and this may be due to the increase in valency 
of the IgG aggregate. At a higher dose (1000 Gy) this effect 
was reduced, where binding was only enhanced by 20%, and 
this may reflect a gross disruption in the conformation caused 
by many molecular changes and the total aggregation of the 
monomeric form [20]. Exposure of IgG to the longer lived 
ROO" [14], which has similar properties to peroxy moieties 
generated uring lipid peroxidation, induced a linear dose- 
dependent increase in Clq binding. Our studies have pre- 
Table 2 
Effects of denaturation of IgG by ROS on the subsequent interac- 
tion of IgG with Clq: the effect of activated polymorphonuclear 
leukocytes on IgG and its interaction with Clq 
IgG treatment Mean Clq binding activity-- 
absorbance at492 nm+ SEM 
IgG + PMNs 0.217 + 0.014 
IgG + PMNs + PMA 0.183 + 0.09* 
The Clq binding activity of IgG which has been exposed to activated 
and resting PMNs is shown as mean absorbance r adings at 492 
nm + SEMs generated in the modified ELISA. 
*P < 0.05 (n = 4). 
viously shown that ROO" attack results in autofluorescence 
but not aggregation. The proposed Clq binding site lies in 
the following sequence: glu-tyr-lys-cys-lys, and the observed 
elevation in reactivity with Clq may be due to cleavage of 
disulphide bridges or increases in hydrophobicity following 
ROO" treatment. Increases in hydrophobicity are common 
following ROS damage to proteins [21], and such modifica- 
tions increase the avidity of protein-protein i teractions. Ex- 
posure of IgG to 02-" did not affect IgG and Clq interaction. 
Previously we have reported that 02-" is unable to induce any 
changes in the macromolecular structure of IgG [19]. Chemi- 
cal and physicochemical studies have shown that 02-" is 
rarely damaging per se and is damaging indirectly in aqueous 
solution only through the more reactive radical species, OH" 
[221. 
Catalytic metal ion availability has long been implicated in 
ROS generation in situ. Site-specific generation of OH" on 
IgG by H202 in the presence of Cu via the Fenton reaction 
reduced the subsequent interaction of IgG with Clq. This 
effect was not seen when IgG was incubated with copper in 
the absence of H202 (data not shown). Altered binding may 
reflect ROS-induced changes in critical amino acid residues. A
recent report has described increased levels of copper in the 
synovial fluid of rheumatoid patients [23]. This is largely com- 
plexed to albumin providing a sink for site-specifically gener- 
ated ROS. A comparison between our data on the Clq bind- 
ing activity of SF IgG and Cu-H2Oz-treated IgG supports the 
observation that copper chelation with subsequent local OH" 
production on IgG is unlikely to play a role in the altered Clq 
binding observed in rheumatoid arthritis. 
Exposure of IgG to HOC1 does not affect Clq binding 
capacity, but at concentrations > 1 mM, HOC1 can induce 
monomeric autofluorescence in IgG in a similar manner to 
that described for ROO" [20]. This indicates that whilst fluor- 
escence can result from exposure to an oxidative flux, changes 
to the residues involved in fluorescence ( .g. tryptophan, tyr- 
osine) are unlikely to account for altered Clq binding. 
Isolated polymorphs activated in vitro to produce 02-" in- 
duce denaturative changes in IgG similar to those induced by 
the Fenton system. H2Oz is the secondary ROS generated 
from the dismutation of O2-', and its increased hydrophobic- 
ity and half-life when compared with other ROS facilitate its 
reactivity with metal ions at distant sites. 
We have previously shown that OH" can cause a loss in 
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Fig. 2. The percentage change in binding of modified IgG to Clq is 
shown for OH', ROO', and 02" treated IgG. Steady-state 7 radi- 
olysis generates specific radicals in solution, where an increase in ir- 
radiation dose is paralleled by an increase in ROS concentration. 
The results are expressed as the mean+SEMs of three experiments, 
and compared with the unirradiated control; *P< 0.05, **P< 0.01. 
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galactose on the IgG glycoform [12], a phenomenon also ob- 
served in rheumatoid IgG. Whilst a study of an aglycosylated 
mouse/human chimeric antibody has confirmed a loss in C lq  
binding and complement activation [10], it remains to be elu- 
cidated whether the deletion of a single galactose moiety could 
modulate C lq  binding effects. 
Further studies on the appearance of complement products 
are required before implications can be made about the patho- 
logical consequences of ROS denaturation of IgG and the 
interaction of denatured IgG with the complement cascade. 
However, this study has shown that IgG has increased C lq  
binding activity in rheumatoid synovial fluid. We suggest hat 
specific residues in the CH2 domain of IgG are affected by 
ROS, the nature of the effect being governed by the radical 
species. 
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